arrow
X

Xavier Declèves

assistance publique hopitaux paris
H指数:45
被引数:6,260

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAFV600E/K-mutant metastatic melanoma

恩考拉芬尼和比尼替尼在BRAFV600E/K突变转移性黑色素瘤真实世界患者中的群体药代动力学

2026-03-170
PRE
Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
2026-01-200
PRE
Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients

利妥昔单抗诱导和维持方案在抗中性粒细胞胞浆抗体(ANCA)相关性血管炎中的比较:真实世界患者中ANCA和免疫球蛋白G水平的药代动力学/药效学建模

2025-11-030
OAAI
LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis

LC-MS/MS法用于测定接受抗中性粒细胞胞浆抗体相关性血管炎治疗的患者人血浆中avacopan的浓度

2025-09-200
OAAI
Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation

禁食通过PPAR δ 激活上调大鼠血脑屏障的单羧酸转运蛋白MCT1

2024-04-081
OAAI
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
2024-03-260
PRE
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
2024-01-251
PRE
Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs

人类志愿者和用止痛药或精神药物治疗的患者中CYP450和P-糖蛋白的表型指数

2023-03-185
OAAI
Cytochromes P450 and P-Glycoprotein Phenotypic Assessment to Optimize Psychotropic Pharmacotherapy: A Retrospective Analysis of Four Years of Practice in Psychiatry

细胞色素P450和P-糖蛋白表型评估以优化精神药物治疗: 对精神病学四年实践的回顾性分析

2022-11-084
OAAI